ClinicalTrials.Veeva

Menu

Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)

M

Murdoch Childrens Research Institute

Status

Completed

Conditions

Dermatitis, Atopic

Treatments

Other: standard clothing
Other: wool clothing

Study type

Interventional

Funder types

Other

Identifiers

NCT04011215
2019.034

Details and patient eligibility

About

The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood atopic dermatitis (eczema) over two consecutive six-week periods.

Full description

The study will aim for a sample size of approximately 150 participants (equally distributed between 3 international sites) between the ages of 3 months and 5 years referred to the respective Dermatology Departments for management of moderate to severe atopic dermatitis. They will be sequentially recruited and randomized to the wool-to-standard clothing arm or standard clothing-to-wool arm.

The study will run for 12 weeks for each participant with two consecutive 6-week periods for each intervention, either of wool followed by standard clothing or standard followed by wool clothing. Participants will be assessed by a blinded trained researcher, at their initial appointment, 3 weeks, 6 weeks, 9 weeks and 12 weeks post commencement of the first intervention.

The primary outcome is the severity of atopic dermatitis at 6 weeks post commencement of each intervention i.e.at week 6 and week 12. Severity of atopic eczema will be measured using the Eczema Area and Severity Index (EASI).

Secondary outcomes include the severity and change in the severity of eczema using the EASI at 3 weeks, the validated Investigators Global Assessment for atopic dermatitis (vIGA-AD™) score and quality of life assessment using the children's Dermatology Life Quality Index (cDLQI) at 3 and 6 weeks of each 6 week intervention period, as well as weekly Patient Oriented SCORing Atopic Dermatitis index (PO-SCORAD) scores.

Enrollment

19 patients

Sex

All

Ages

3 months to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Is aged between 3 months and 5 years of age at the time of recruitment
  • Has moderate to severe eczema as determined by an EASI score of 7 or above at their initial visit
  • Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf

Exclusion criteria

  • Has a known allergic contact dermatitis to wool or merino wool
  • Is unable to attend all scheduled visits
  • Has unstable eczema defined by an escalation of treatment requirements during the preceding 6 weeks. This would include flares of AD for any reason including infection, food allergy etc.
  • Use of systemic corticosteroids within 6 weeks of study start.
  • Any medical reason that is considered by the principal investigator to preclude enrolment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

19 participants in 2 patient groups

wool-first (wool X standard)
Experimental group
Description:
superfine merino wool clothing to be worn for 6 weeks followed by 6 weeks of standard clothing
Treatment:
Other: wool clothing
Other: standard clothing
standard-first (standard X wool)
Active Comparator group
Description:
standard clothing to be worn for 6 weeks followed by 6 weeks of superfine merino wool clothing
Treatment:
Other: wool clothing
Other: standard clothing

Trial contacts and locations

1

Loading...

Central trial contact

John C Su, FACD, FRACP; Adrian J Lowe, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems